EUVIMEDEUVIMED entdecken
Open Access

Investigating the In Vivo Biodistribution of Extracellular Vesicles Isolated from Various Human Cell Sources Using Positron Emission Tomography

Zachary T Rosenkrans, Anna S Thickens, John A Kink, Eduardo Aluicio-Sarduy, Jonathan W Engle iD, Peiman Hematti iD, Reinier Hernandez iD

Molecular Pharmaceutics · 02.09.2024 · 21 (9) · 4324-4335

DOI: 10.1021/acs.molpharmaceut.4c00298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 21.08.2024. Verfasst von Zachary T Rosenkrans und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medical Physics and Radiology, University of Wisconsin-Madison, 1111 Highland Avenue, Madison, Wisconsin 53705, United States. Hauptthemen laut MEDLINE: Extracellular Vesicles, Positron-Emission Tomography, Mesenchymal Stem Cells. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Positron emission tomography (PET) is a powerful tool for investigating the in vivo behavior of drug delivery systems. We aimed to assess the biodistribution of extracellular vesicles (EVs), nanosized vesicles secreted by cells isolated from various human cell sources using PET. EVs were isolated from mesenchymal stromal cells (MSCs) (MSC EVs), human macrophages (Mϕ EVs), and a melanoma cell line (A375 EVs) by centrifugation and were conjugated with deferoxamine for radiolabeling with Zr-89. PET using conjugated and radiolabeled EVs evaluated their in vivo biodistribution and tissue tropisms. Our study also investigated differences in mouse models, utilizing immunocompetent and immunocompromised mice and an A375 xenograft tumor model. Lastly, we investigated the impact of different labeling techniques on the observed EV biodistribution, including covalent surface modification and membrane incorporation. PET showed that all tested EVs exhibited extended in vivo circulation and generally low uptake in the liver, spleen, and lungs. However, Mϕ EVs showed high liver uptake, potentially attributable to the intrinsic tissue tropism of these EVs from the surface protein composition. MSC EV biodistribution differed between immunocompetent and immunodeficient mice, with increased spleen uptake observed in the latter. PET using A375 xenografts demonstrated efficient tumor uptake of EVs, but no preferential tissue-specific tropism of A375 EVs was found. Biodistribution differences between labeling techniques showed that surface-conjugated EVs had preferential blood circulation and low liver, spleen, and lung uptake compared to membrane integration. This study demonstrates the potential of EVs as effective drug carriers for various diseases, highlights the importance of selecting appropriate cell sources for EV-based drug delivery, and suggests that EV tropism can be harnessed to optimize therapeutic efficacy. Our findings indicate that the cellular source of EVs, labeling technique, and animal model can influence the observed biodistribution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesPositron-Emission TomographyMesenchymal Stem CellsAnimalsHumansTissue DistributionMiceCell Line, TumorMacrophagesZirconiumDeferoxamineRadioisotopesDrug Delivery SystemsXenograft Model Antitumor AssaysFemaleMelanoma

Stichwörter der Autor:innen

biodistributioncancerexosomesextracellular vesiclesimagingpositron emission tomography

Substanzen

ZirconiumZirconium-89DeferoxamineRadioisotopes

Autor:innen und Institutionen

  • Departments of Medical Physics and Radiology, University of Wisconsin-Madison, 1111 Highland Avenue, Madison, Wisconsin 53705, United States.
  • Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, 1685 Highland Avenue, Madison, Wisconsin 53705, United States.
  • University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, 600 Highland Avenue, Madison, Wisconsin 53792, United States.
  • Division of Hematology and Oncology, Medical College of Wisconsin, 9200 W. Wisconsin Avenue, Milwaukee, Wisconsin 53226, United States.

ORCID-Profile: Jonathan W Engle, Peiman Hematti, Reinier Hernandez

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Cancer Institute
  • National Heart, Lung, and Blood Institute
  • U.S. Department of Defense
  • University of Wisconsin-Madison

Zitieren

APA

Rosenkrans, Z. T., Thickens, A. S., Kink, J. A., Aluicio-Sarduy, E., Engle, J. W., Hematti, P., & Hernandez, R. (2024). Investigating the In Vivo Biodistribution of Extracellular Vesicles Isolated from Various Human Cell Sources Using Positron Emission Tomography. Molecular Pharmaceutics, 21(9), 4324-4335. https://doi.org/10.1021/acs.molpharmaceut.4c00298

Vancouver

Rosenkrans ZT, Thickens AS, Kink JA, Aluicio-Sarduy E, Engle JW, Hematti P, et al. Investigating the In Vivo Biodistribution of Extracellular Vesicles Isolated from Various Human Cell Sources Using Positron Emission Tomography. Molecular Pharmaceutics. 2024;21(9):4324-4335. doi:10.1021/acs.molpharmaceut.4c00298

BibTeX
@article{Rosenkrans2024,
  author = {Rosenkrans, Zachary T and Thickens, Anna S and Kink, John A and Aluicio-Sarduy, Eduardo and Engle, Jonathan W and Hematti, Peiman and Hernandez, Reinier},
  title = {Investigating the In Vivo Biodistribution of Extracellular Vesicles Isolated from Various Human Cell Sources Using Positron Emission Tomography},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  volume = {21},
  number = {9},
  pages = {4324--4335},
  doi = {10.1021/acs.molpharmaceut.4c00298}
}
Kostenlos starten →